Porphyrin-based MOFs for Gene Delivery in Cancer Therapy: Recent Advances and Progress

Area of Science:

• Materials Science
• Nanotechnology
• Oncology

Background:

• Cancer remains a leading cause of death, with conventional chemotherapy drugs exhibiting limitations like poor pharmacokinetics and severe side effects.
• Porphyrins, known for their unique properties, have applications in photodynamic therapy and imaging but face challenges in aqueous environments, including aggregation and poor stability.
• Metal-organic frameworks (MOFs) have emerged as promising nanocarriers for drug delivery systems.

Purpose of the Study:

• To explore the development and application of porphyrin-based MOFs for advanced cancer therapy.
• To address the limitations of traditional chemotherapies and standalone porphyrin compounds in treating cancer.
• To investigate the potential of porphyrin-MOFs in enhancing drug delivery, targeting, and overcoming tumor biological barriers.

Main Methods:

• Synthesis of porphyrin-based metal-organic frameworks (MOFs) using self-assembly of metal ions/clusters and porphyrin linkers.
• Integration of porphyrin-MOFs into drug delivery systems for cancer treatment.
• Evaluation of therapeutic functions, targeting mechanisms, and overcoming of tumor barriers like hypoxia.

Main Results:

• Porphyrin-based MOFs retain the beneficial properties of porphyrins while offering enhanced advantages.
• These MOFs demonstrate potential in combination therapies, advanced drug delivery, and photodynamic therapy for cancer.
• The developed MOFs show promise in improving targeting, safety, and drug delivery efficiency, while also addressing challenges like tumor hypoxia.

Conclusions:

• Porphyrin-based MOFs represent a transformative strategy in cancer treatment.
• They offer integrated therapeutic functions, improved targeting, and enhanced drug delivery efficiency.
• Ongoing development of porphyrin-MOFs paves the way for more personalized and effective cancer therapies.